Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
3.140
-0.440 (-12.29%)
Mar 31, 2025, 2:26 PM EDT - Market open
Mainz Biomed Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Mainz Biomed stock has a target of 14, which predicts an increase of 345.86% from the current stock price of 3.14.
Analyst Consensus: Buy
* Price targets were last updated on Feb 14, 2025.
Analyst Ratings
The average analyst rating for Mainz Biomed stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +345.86% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $120 | Strong Buy | Maintains | $200 → $120 | +3,721.66% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2023 |
Financial Forecast
Revenue This Year
1.08M
from 895.48K
Increased by 20.94%
Revenue Next Year
1.28M
from 1.08M
Increased by 18.01%
EPS This Year
-17.56
from -64.76
EPS Next Year
-6.68
from -17.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.1M | 1.5M | 1.2M | ||
| Avg | 1.1M | 1.3M | 1.2M | ||
| Low | 1.0M | 1.1M | 1.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.6% | 35.7% | -4.7% | ||
| Avg | 20.9% | 18.0% | -7.4% | ||
| Low | 15.1% | - | -11.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -11.38 | -4.10 | -1.97 |
| Avg | -17.56 | -6.68 | -1.92 |
| Low | -23.13 | -9.02 | -1.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.